Advances in assessing donor organ quality and perioperative risk for kidney transplantation
Kidney International · 2026-11
DOI: 10.1016/j.kint.2026.07.040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Kidney International, 2026-11. Verfasst von You Zuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery - Organ Donation and Transplantation, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Die Arbeit nennt 107 Literaturangaben.
Abstract (Originalsprache)
Kidney transplantation faces persistent challenges in accurately evaluating donor organ quality and predicting long-term outcomes, with traditional assessment methods demonstrating limited predictive capacity. The increasing utilization of marginal-quality donor organs has intensified the need for sophisticated evaluation strategies. Machine perfusion technology has transformed organ preservation from mere static storage to a dynamic platform potentially enabling real-time monitoring, assessment, and interventions during the preservation period. Molecular profiling technologies such as genomics, transcriptomics, proteomics, and metabolomics could provide refined biomarkers for donor kidney assessment across several phases of kidney transplantation. The first window arises during donor evaluation. Techniques such as high-resolution molecular typing, genetic profiling, epigenomic markers, and artificial intelligence-enhanced imaging provide additional information compared to traditional scoring systems. During organ preservation, a second window emerges, allowing additional, isolated assessment of the organ after procurement but before transplantation. Machine perfusion systems enable sampling of perfusate and tissue for multi-omics analysis to characterize injury or function, although most candidate biomarkers remain at the discovery or early validation stage. After transplantation, donor-derived cell-free deoxyribonucleic acid, urinary chemokines, and advanced imaging modalities offer non-invasive early detection of graft injury. Clinical translation of these new techniques faces substantial challenges: most studies are single-center and have small sample sizes, assay standardization remains incomplete, and evidence linking biomarker-guided decisions to improved long-term graft survival is lacking. Machine learning may enhance risk stratification but remains largely unvalidated in prospective trials. Future progress requires a shift from short-term endpoint prediction to long-term outcome validation through multicenter studies, standardized protocols, and equitable implementation strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery - Organ Donation and Transplantation, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- Department of Surgery - Organ Donation and Transplantation, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: c.moers@umcg.nl.
Zitieren
APA
Zuo, Y., Lantinga, V. A., Orozco-García, E., Ogurlu, B., & Moers, C. (2026). Advances in assessing donor organ quality and perioperative risk for kidney transplantation. Kidney International. https://doi.org/10.1016/j.kint.2026.07.040
Vancouver
Zuo Y, Lantinga VA, Orozco-García E, Ogurlu B, Moers C. Advances in assessing donor organ quality and perioperative risk for kidney transplantation. Kidney International. 2026. doi:10.1016/j.kint.2026.07.040
BibTeX
@article{Zuo2026,
author = {Zuo, You and Lantinga, Veerle A and Orozco-García, Elizabeth and Ogurlu, Baran and Moers, Cyril},
title = {Advances in assessing donor organ quality and perioperative risk for kidney transplantation},
journal = {Kidney International},
year = {2026},
doi = {10.1016/j.kint.2026.07.040}
}
EUVIMED